The Lancet Neurology in conversation with
En podcast af The Lancet Group - Torsdage
187 Episoder
-  Giuseppe Citerio on frailty and TBIUdgivet: 19.1.2022
-  Alberto Costa on memantine in adolescents and young adults with Down syndromeUdgivet: 20.12.2021
-  Olivier Rascol on amantadine for patients with movement disordersUdgivet: 17.11.2021
-  Antonio Uccelli on stems cells for MSUdgivet: 20.10.2021
-  Priya Palta on blood pressure control and cognitive declineUdgivet: 15.9.2021
-  Adam Boxer on tau biomarkersUdgivet: 18.8.2021
-  Irene Cortese on the difficulties of designing clinical trialsUdgivet: 21.7.2021
-  Doug Turnbull on mitochondrial diseases in adultsUdgivet: 16.6.2021
-  Geert Jan Biessels on predicting post-stroke cognitive impairmentUdgivet: 19.5.2021
-  Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALSUdgivet: 21.4.2021
-  Anne MacGregor on menstrual migraineUdgivet: 17.3.2021
-  Peter Rothwell on asymptomatic carotid stenosis and strokeUdgivet: 17.2.2021
-  Spinal cord injury and degenerative cervical myelopathyUdgivet: 20.1.2021
-  Genetic risk factors for sCJDUdgivet: 22.12.2020
-  Prednisone in short-term prevention of cluster headacheUdgivet: 24.11.2020
-  PET imaging of inflammation in neurological and psychiatric disordersUdgivet: 21.10.2020
-  Neurological associations of COVID-19Udgivet: 4.9.2020
-  Advances in understanding of Rett syndromeUdgivet: 31.7.2020
-  Management of Parkinson's diseaseUdgivet: 17.6.2020
-  Optimal time to treat Huntington's DiseaseUdgivet: 26.5.2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
 
 